Angiocrine Bioscience
PrivateLast Round
VC Round
Sep 4, 2025
Total Funding Raised
$45.83M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Angiocrine Bioscience is a biotechnology company that develops a curative cellular therapies platform aimed at treating conditions in regenerative medicine and hematopoietic stem cell gene therapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Angiocrine Bioscience Comparables
Compare Angiocrine Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gamida Cell Ltd. | 76% | |
| Ossium Health | 71% | |
| Pluri | 69% | |
Angiocrine Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 4, 2025 | ||||
| Grant | Dec 19, 2022 | ||||
| Grant | Dec 15, 2022 | ||||
| Series B | Mar 29, 2022 | ||||
| Grant | Aug 24, 2017 | ||||
Grant | Feb 23, 2017 |
Angiocrine Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Good Growth Capital | Series B |
| California Institute for Regenerative Medicine | Grant |
| Cobro Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 416% MoM, from 462 to 2.4K.
- Aug 21, 2015
$2.1M round completed.
Angiocrine Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Angiocrine Bioscience's valuation, stock price, and market status.